Evidence map›Paper›PMID 29702603›Full record

GuidelineNutrients2018

Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults.

Roberto Cesareo, Roberto Attanasio, Marco Caputo, Roberto Castello, Iacopo Chiodini, Alberto Falchetti, Rinaldo Guglielmi, Enrico Papini, Assunta Santonati, Alfredo Scillitani and 5 more

Open access · goldAbstract readPractice GuidelineReview
In one paragraph

Guideline in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 1 country.

Roberto CesareoDepartment of Internal Medicine, "S. M. Goretti" Hospital, 04100 Latina, Italy. robertocesareo@libero.it.
Roberto AttanasioEndocrinology Service, Galeazzi Institute IRCCS, 20161 Milan, Italy. roberto.serena@libero.it.ORCID 0000-0002-1417-287X
Marco CaputoOspedale Classificato Villa Salus, 30174 Venezia Mestre, Italy. cptmrc@gmail.com.
Roberto CastelloGeneral Medicine and Endocrinology, University Hospital, 37126 Verona, Italy. roberto.castello@aovr.veneto.it.
Iacopo ChiodiniUnit for Bone Metabolism Diseases and Diabetes & Lab of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy. iacopo.chiodini@unimi.it.ORCID 0000-0001-7594-3300
Alberto FalchettiCentro Hercolani and Villa Alba (GVM), 40123 Bologna and EndOsMet, Villa Donatello Private Hospital, 50132 Florence, Italy. alberto.falchetti2@alice.it.ORCID 0000-0002-6739-4417
Rinaldo GuglielmiDepartment of Endocrinology and Metabolic Diseases, Regina Apostolorum Hospital, Albano Laziale, 00041 Rome, Italy. rinaldo.guglielmi@gmail.com.
Enrico PapiniDepartment of Endocrinology and Metabolic Diseases, Regina Apostolorum Hospital, Albano Laziale, 00041 Rome, Italy. papinie@gmail.com.
Assunta SantonatiDepartment of Endocrinology, San Giovanni Addolorata Hospital, 00184 Rome, Italy. a.santonati1@fastwebnet.it.
Alfredo ScillitaniEndocrinology Unit, Department of Medical Science, Ospedale Casa Sollievo della Sofferenza IRCCS, 71013 San Giovanni Rotondo (FG), Italy. alscill@tin.it.
Vincenzo ToscanoEndocrinology, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Roma, Italy. vincenzo.toscano@uniroma1.it.
Vincenzo TriggianiInterdisciplinary Department of Medicine, Endocrinology and Metabolic Diseases, University of Bari "Aldo Moro", 70124 Bari, Italy. vincenzo.triggiani@uniba.it.
Fabio VesciniDepartment of Endocrinology and Diabetes, Santa Maria della Misericordia Hospital, 33010 Udine, Italy. fabio.vescini@asuiud.sanita.fvg.it.
Michele ZiniEndocrinology Unit, Arcispedale S. Maria Nuova IRCCS, 42123 Reggio Emilia, Italy. michele.zini@ausl.re.it.
AME and Italian AACE ChapterDepartment of Internal Medicine, "S. M. Goretti" Hospital, 04100 Latina, Italy.
Ospedale Regina Apostolorum · ITAzienda Ospedaliera San Giovanni Addolorata · ITAzienda Ospedaliera Sant'Andrea · ITCasa Sollievo della Sofferenza · ITIstituto Ortopedico Galeazzi · ITOspedale Civile di Venezia · ITOspedale Santa Maria della Misericordia di Udine · ITOspedale Santa Maria Goretti · ITUniversity of Bari Aldo Moro · ITUniversity of Milan · ITUniversity of Verona · ITVilla Torri Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D deficiency is very common and prescriptions of both assay and supplementation are increasing more and more. Health expenditure is exponentially increasing, thus it is timely and appropriate to establish rules. The Italian Association of Clinical Endocrinologists appointed a task force to review literature about vitamin D deficiency in adults. Four topics were identified as worthy for the practicing clinicians. For each topic recommendations based on scientific evidence and clinical practice were issued according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) System. (1) What cut-off defines vitamin D deficiency: even though 20 ng/mL (50 nmol/L) can be considered appropriate in the general population, we recommend to maintain levels above 30 ng/mL (75 nmol/L) in categories at risk. (2) Whom, when, and how to perform screening for vitamin D deficiency: categories at risk (patients with bone, liver, kidney diseases, obesity, malabsorption, during pregnancy and lactation, some elderly) but not healthy people should be screened by the 25-hydroxy-vitamin D assay. (3) Whom and how to treat vitamin D deficiency: beyond healthy lifestyle (mostly sun exposure), we recommend oral vitamin D (vitamin D2 or vitamin D3) supplementation in patients treated with bone active drugs and in those with demonstrated deficiency. Dosages, molecules and modalities of administration can be profitably individually tailored. (4) How to monitor the efficacy of treatment with vitamin D: no routine monitoring is suggested during vitamin D treatment due to its large therapeutic index. In particular conditions, 25-hydroxy-vitamin D can be assayed after at least a 6-month treatment. We are confident that this document will help practicing clinicians in their daily clinical practice.

Indexed as

Dietary SupplementsAdultAgedAged, 80 and overBiomarkersConsensusEndocrinologyFemaleHumansItalyMaleMiddle AgedPredictive Value of TestsRisk FactorsTime FactorsTreatment Outcome25-hydroxyvitamin DBiomarkersVitamin DbonecalcifediolcalcitriolcholecalciferolergocalciferolVitamin D

Identifiers

PMID29702603
PMCPMC5986426
OpenAlexW2802217640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.